Trial intelligence / Profile preview

Candesartan for Cocaine Dependence

NCT01938664Phase 2Terminated

Sponsor
Baylor College of Medicine
Start
Jan 2013
Primary completion
Jul 2016
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 2 trial of candesartan in cocaine dependence, sponsored by Baylor College of Medicine. Started Jan 2013; status: terminated.

02

Drugs

candesartan
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT01938664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01938664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call